Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCD-CARRE
NCT04084080Phase 3Active, not recruiting
- Sponsor
- University of Pittsburgh
- Start
- Feb 2020
- Primary completion
- May 2026
- Countries
- 3
01
Overview
A Phase 3 trial of red blood cells in sickle cell disease (SCD), sponsored by University of Pittsburgh. Started Feb 2020; status: active, not recruiting.
02
Drugs
red blood cells
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT04084080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04084080.